Liraglutida, administrada a una dosis de 1,8mg diarios durante 48 semanas, demostr resolucin de la esteatohepatitis no alcohlica (sin empeoramiento de la fibrosis) en el 39% de los pacientes, en comparacin con el 9% con placebo, en un ensayo de fase 2 que incluy a 23 pacientes con obesidad (IMC 34,24,7kg/m2) y evidencia clnica de esta enfermedad
If youre considering fat dissolving injections, its important to consult with a qualified medical professional to determine if its the right option for you and to discuss potential risks and benefits
Am J Clin Nutr 83:12561264
A 2024 study from Epic Research found that people with hypothyroidism who lost more than 5 pounds while taking GLP-1 medications (including semaglutide) saw TSH (thyroid-stimulating hormone) levels decrease by an average of about 0.55 mU/L
Semaglutide users typically see a reduction in this marker, which indicates better management of diabetes
Ozempic is used to treat Type 2 diabetes and Wegovy is used for weight loss
